With the current concerns related to opioid addiction and overdose, researchers from the National Institute on Drug Abuse (NIDA) are exploring ways to reduce the use of opioids for pain relief, while still effectively managing pain. In a randomized clinical trial, 422 patients undergoing a variety of operations were given the medicine gabapentin during and after surgery, while other patients were given placebos. Gabapentin is an anti-epileptic medication (an anticonvulsant) and is also used in adults to treat certain kinds of nerve pain.
After surgery, researchers then noted the patient’s use of opioids. They measured not only their need for opioids to manage postsurgical pain, but also how quickly these patients were ready to stop using opioids. The study showed that 72 hours of perioperative gabapentin did not eliminate postsurgical pain more quickly, but it did significantly reduce the duration of opioid use. These findings suggest that gabapentin may be a valuable adjuvant to prevent the development of postoperative chronic opioid use.
The study was sponsored by the National Institute on Drug Abuse and the Stanford Department of Anesthesiology.
For a copy of the study, go to "Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial," published in the JAMA Surgery.
For more information about opioids, go to: https://www.drugabuse.gov/drugs-abuse/opioids.
NIDA Press Office
About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to email@example.com. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH. . .Turning Discovery Into Health®